Cerenome adopts new name and Nasdaq ticker CNSY
Cerenome, Inc., formerly Plus Therapeutics, Inc., implemented a corporate name change effective August 3, 2026.
Rhea-AI Filing Summary
Cerenome, Inc., formerly Plus Therapeutics, Inc., implemented a corporate name change effective August 3, 2026. A Certificate of Amendment to its Amended and Restated Certificate of Incorporation was filed in Delaware on July 30, 2026 to effect this change.
In connection with the name change, the company’s common stock, par value $0.001 per share, began trading on the Nasdaq Capital Market under the new ticker symbol “CNSY” at the start of trading on August 3, 2026. The company states that there is no change to its CUSIP as a result of the name or trading symbol change, and it has updated its bylaws to reflect the new corporate name.
Positive
- None.
Negative
- None.
8-K Event Classification
2 items: 5.03, 9.01
2 items
Item 5.03
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Governance
The company amended its charter documents, bylaws, or changed its fiscal year.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Effective date of name change: August 3, 2026
Amendment filing date: July 30, 2026
Par value of common stock: $0.001 per share
3 metrics
Effective date of name change
August 3, 2026
Date corporate name changed from Plus Therapeutics, Inc. to Cerenome, Inc.
Amendment filing date
July 30, 2026
Date Certificate of Amendment was filed with Delaware Secretary of State
Par value of common stock
$0.001 per share
Par value of Cerenome, Inc. common stock listed on the Nasdaq Capital Market
Key Terms
Certificate of Amendment, Amended and Restated Certificate of Incorporation, CUSIP, Inline XBRL
4 terms
Certificate of Amendment regulatory
"filed a Certificate of Amendment to its Amended and Restated Certificate"
A certificate of amendment is an official filing that updates a company’s founding documents—its legal “rulebook” that sets share structure, voting rules, name and basic purpose. Think of it like changing the blueprint of a building: small changes are paperwork, big ones can alter who owns how much and who controls decisions. Investors watch these filings because they can affect share counts, voting power, dilution and company value.
Amended and Restated Certificate of Incorporation regulatory
"Certificate of Amendment to its Amended and Restated Certificate of Incorporation"
A company’s amended and restated certificate of incorporation is an updated version of its foundational legal charter that replaces the older document and folds in all changes into one clear copy; it spells out corporate structure, classes of stock, shareholder rights and key governance rules. Investors care because it can change who controls the company, how votes are counted, what claims shareholders have on assets or dividends, and can introduce or remove protections against takeovers—like updating a house title after a major renovation to show who owns what and under what rules.
CUSIP financial
"There will be no change to the Company’s CUSIP in connection with the Name Change"
A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What corporate change did PSTV (now Cerenome, Inc.) disclose?
The company changed its corporate name from Plus Therapeutics, Inc. to Cerenome, Inc., effective August 3, 2026, by filing a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Delaware Secretary of State.
When did Cerenome, Inc. (PSTV) file the amendment for its name change?
Cerenome, Inc. filed the Certificate of Amendment on July 30, 2026. The amendment changed the corporate name from Plus Therapeutics, Inc. to Cerenome, Inc., with the name change becoming effective on August 3, 2026.
What is the new Nasdaq trading symbol for Cerenome, Inc. (PSTV)?
The company’s common stock now trades on the Nasdaq Capital Market under the symbol “CNSY”. Shares of common stock began trading under this new ticker at the commencement of trading on August 3, 2026.
Did Cerenome, Inc. change its CUSIP with the new name and ticker?
No, the company states there will be no change to its CUSIP in connection with either the corporate name change to Cerenome, Inc. or the Nasdaq trading symbol change to “CNSY”.
What is the par value of Cerenome, Inc.’s common stock after the name change?
The company’s common stock continues to have a par value of $0.001 per share. The name and ticker symbol changes do not alter the par value or basic terms of the existing common stock.
Which corporate governance documents did Cerenome, Inc. update?
Cerenome, Inc. submitted a Certificate of Amendment to its Amended and Restated Certificate of Incorporation and also provided updated bylaws reflecting the new corporate name, both of which became effective on August 3, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
